Podcast Episodes
Back to SearchFibroblasts In Regenerative Medicine with FibroBiologics' Pete O'Heeron & Dr. Hamid Khoja
We love to hear from our listeners. Send us a message.
FibroBiologics Chairman, CEO, & Founder Pete O'Heeron shares the journey that led him from cli…
4 years, 2 months ago
Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management
We love to hear from our listeners. Send us a message.
To fully appreciate the work Pyxis Oncology is doing in its development of site-specific ADCs …
4 years, 2 months ago
The Biotech Beatdown With Allan Shaw
We love to hear from our listeners. Send us a message.
On this, the 100th episode of the Business of Biotech podcast, our dear friend, frequent guest…
4 years, 2 months ago
Inflammation & Antibodies with Ampio Pharmaceuticals' Mike Martino, CEO
We love to hear from our listeners. Send us a message.
Ampio Pharmaceuticals is currently weaving the gauntlet of a clinical hold triggered by COVID'…
4 years, 2 months ago
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.
We love to hear from our listeners. Send us a message.
As COVID-19 cases climb yet again, the Business of Biotech catches up with Tonix Pharmaceutic…
4 years, 3 months ago
Running Interference: RNAi with Silence Therapeutics' Craig Tooman
We love to hear from our listeners. Send us a message.
Fresh on the heels of his appointment as President & CEO at Silence Therapeutics, Craig Tooman…
4 years, 3 months ago
Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
We love to hear from our listeners. Send us a message.
4D pharma's flagship early-stage clinical candidates are live biotherapeutics, a relatively ne…
4 years, 3 months ago
Gene Tx For Renal Disease With Purespring CEO Richard Francis
We love to hear from our listeners. Send us a message.
Purespring Therapeutics launched in 2020 on the back of IP developed by renowned kidney resear…
4 years, 3 months ago
Fighting Blindness & Funding The Fight With Opus Genetics' CEO Ben Yerxa, Ph.D.
We love to hear from our listeners. Send us a message.
Opus Genetics is an early-stage gene therapy company launched just last year and in unique fas…
4 years, 4 months ago
Gynecological Cancer Therapies with Context Therapeutics' Martin Lehr
We love to hear from our listeners. Send us a message.
Context Therapeutics Co-Founder & CEO Martin Lehr shares stories from his self-described "rec…
4 years, 4 months ago